. >> takeda, the largest drugmaker in japan, said the deal marks the thifrd biggest purchase by japanese company. it sold products including medication for lung ailments in europe, russia and emerging countries across central and south america. takeda plans to expand sales in those growing markets through the acquisition as sales of its main products are on the decline due to the expiration of patents. in the pharmaceutical sector, drugmakers from around the world have been moving into emerging markets that offer hypo terriig potential for expansion. the rival is expected to pick up steam. >>> tokyo stocks are moving within a narrow range friday morning. investors are sidelined as uncertainties surround the corporate outlook. the nikkei index closed the morning session at 9,648, that's down 28 points, a loss of a little over a quarter of a percent. some export-related stocks were bought following the overnight rise in new york shares while utilities dropped due to concerns over a worse outlook. all eyes are on tepco which will release its earnings report later in the day. >>> on the toky